TNFSF13 Antikörper
Kurzübersicht für TNFSF13 Antikörper (ABIN6757705)
Target
Alle TNFSF13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Recognizes human APRIL.
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Highly pure (>98%) recombinant human APRIL.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ELISA (0.5 μg/mL), WB (0.1 - 0.2 μg/mL)
Usage: Suitable for use in ELISA and Western Blot. Direct ELISA: 0.5 μg/mL using 100 μL/well, detects 0.2-04 ng/well of recombinant human APRIL. Western Blot: 0.1-0.2 μg/mL. The detection limit is 1.5-3 ng/lane, under either reducing or non-reducing conditions. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2. No stabilizing proteins added. No preservative added. Glycerol free
-
Konservierungsmittel
- Without preservative
-
Handhabung
- Aliquot to Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
-
-
- TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))
-
Andere Bezeichnung
- TNFSF13 / APRIL
-
Hintergrund
-
Name/Gene ID: TNFSF13
Family: TNF
Synonyms: TNFSF13, APRIL, CD256, CD256 antigen, TALL-2, TALL2, ZTNF2, TNF-related death ligand 1, TRDL-1, UNQ383/PRO715 -
Gen-ID
- 8741
-
UniProt
- O75888
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
Target
-